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Purpose: To evaluate the clinical outcomes of cataract surgery with implantation of a novel 
model of extended depth of focus (EDOF) intraocular lens (IOL).
Methods: Pilot case series enrolling a total of 27 eyes of 16 patients (49 to 84 years) 
undergoing uncomplicated phacoemulsification cataract surgery with implantation of the 
EDOF IOL Synthesis PLUS (Cutting Edge, Montpellier, France). Near (UNVA, uncorrected 
near visual acuity; DCNVA, distance-corrected near visual acuity) and distance visual acuity 
(uncorrected and corrected distance visual acuity, UDVA and CDVA), monocular defocus 
curve and refractive outcomes were evaluated during a 3-month follow-up.
Results: Mean postoperative UDVA, UNVA and DCNVA were 0.11±0.17, 0.14±0.22 and 0.37 
±0.36 logMAR, respectively. A total of 84.6%, 91.7%, and 96.3% of eyes achieved post-
operative UDVA, UNVA and CDVA of 0.20 logMAR or better. A total of 78.6% of eyes 
achieved postoperative DCNVA of 0.30 logMAR or better. Mean postoperative spherical 
equivalent was −0.76±0.53 D. The distance-corrected visual acuity was maintained on average 
over a value of 0.30 logMAR for the range of defocus levels between +1.00 and −1.50 D.
Conclusion: The implantation of the Synthesis plus EDOF IOL after cataract surgery seems 
to provide functional levels of distance, intermediate and near visual acuity. The near visual 
performance with this new IOL might be significantly enhanced using a micro-monovision 
approach. The results of this pilot study should be confirmed in future clinical trials.
Keywords: presbyopia, cataract surgery, presbyopia-correcting IOL, extended depth of 
focus IOL, defocus curve
Introduction
A fast evolution of presbyopia-correcting intraocular lenses (IOL) has occurred in 
last years, with the development of new models and designs.1,2 Extended depth of 
focus (EDOF) IOLs is one of these options for presbyopia correction that has 
experienced a prolific development in recent years.3 The basic principle behind 
these IOLs is to create a single elongated focal point to enhance the depth of focus 
or range of vision, allowing a functional vision at different distances in presbyopia.4 
This effect can be achieved by inducing controlled levels of spherical aberration,5 
combining refractive and diffractive surfaces to optimize achromatic and chromatic 
aberrations6,7 or using a pinhole design.7
Several studies have been conducted to this date to evaluate the outcomes with 
different commercially available EDOF IOLs, confirming the presence of some 
differences in the clinical performance of some IOL models and consequently in the 
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visual rehabilitation provided.1,2,4,7–21 A common finding 
with all types of EDOF IOLs is an effective visual restora-
tion at intermediate vision, but the level of near vision 
achieved varies significantly among IOL models.1,2,4,7–21 
A novel recent EDOF approach has been developed for 
presbyopia correction based on the combination of pri-
mary and secondary spherical aberrations of opposite 
signs with a transition zone to a peripheral monofocal 
area (Synthesis PLUS, Cutting Edge, Montpellier, 
France). The theoretical aim of this new design is to 
deliver continuous high-contrast vision from distance to 
intermediate vision, while maintaining a functional level 
of near vision and preserving the ocular optical quality 
within an acceptable range to avoid the induction of light 
disturbances, such as halos, glare or starbursts. However, 
to this date, there are no scientific reports on the clinical 
outcomes obtained with this new model of EDOF IOL. 
The aim of the current clinical study was to evaluate the 
clinical outcomes in terms of distance and near visual 
acuities, refractive predictability and binocular defocus 
curve in a sample of eyes undergoing cataract surgery 
with implantation of the Synthesis EDOF IOL.
Methods
Patients
This pilot case series enrolled a total of 27 eyes of 16 
patients undergoing uncomplicated phacoemulsification 
cataract surgery with implantation of the EDOF IOL 
Synthesis PLUS (Cutting Edge, Montpellier, France). All 
patients were adequately informed about the study in the 
preoperative visit and signed a consent form in accordance 
with the tenets of the Declaration of Helsinki. The study 
was approved by the Iradier clinic ethics committee. 
Inclusion criteria were cataract or presbyopic/pre- 
presbyopic patients suitable for refractive lens exchange 
seeking for spectacle independence and predicted post-
operative astigmatism equal or less than 1.00 
D. Exclusion criteria were previous ocular surgery, active 
or systemic ocular pathology, irregular corneal astigma-
tism, abnormal iris, and antecedents of ocular conditions 
such as glaucoma, uveitis or retinal problems.
Clinical Protocol
A complete preoperative ophthalmological examination 
was performed in all patients including manifest refrac-
tion, measurement of monocular uncorrected (UDVA) and 
corrected distance visual acuity (CDVA), corneal 
topography and pachymetry with the Pentacam HR system 
(OCULUS Optikgeräte GmbH, Wetzlar, Germany), slit- 
lamp examination, Goldmann applanation tonometry, opti-
cal biometry and keratometry (IOL Master 700, Carl Zeiss 
Meditec, Jena, Germany), infrared pupillometry and indir-
ect ophthalmoscopy.
Postoperatively, besides the day after surgery, all 
patients were evaluated at 1 month and 3 months post-
operatively. The examination the day after surgery 
included measurement of monocular UDVA and uncor-
rected near visual acuity (UNVA) (40 cm), tonometry 
and biomicroscopic examination of the integrity of the 
anterior segment. At 3 months after surgery, the examina-
tion performed consisted of the following tests: measure-
ment of monocular UDVA and UNVA, manifest refraction, 
measurement of monocular CDVA and distance-corrected 
near visual acuity (DCNVA), slit-lamp biomicroscopic 
examination, and monocular evaluation of the defocus 
curve to evaluate the range of functional function. The 
defocus curve was measured using Snellen charts at 5 m, 
while the patient was wearing the spherocylindrical refrac-
tion providing the best distance visual acuity. Different 
levels of defocus were introduced in 0.5 D steps from 
+0.50 D to −3.50 D, and visual acuity values were 
recorded. All these data were then represented in 
a Cartesian graphic display, with the x-axis showing the 
levels of defocus and the y-axis the visual acuity achieved.
Surgery
All surgeries were performed by the same experienced 
surgeon (MTI) using a standard technique of sutureless 
microincision phacoemulsification. First, anaesthesia and 
mydriatic drops were instilled and the surgery was 
initiated with the creation of the corneal incision at the 
temporal area. After this, the capsulorrhexis was created 
manually and the phacoemulsification was performed. 
Finally, the IOL was inserted into the capsular bag through 
the main incision using the Medicel Accuject Pro 1.6 mm 
injector (Medicel AG, Thal, Switzerland). A combination 
of topical antibiotic and steroid was prescribed to be 
applied postoperatively four times daily for one week.
Intraocular Lens
The Synthesis PLUS IOL is a one-piece EDOF IOL with 
a 6.0-mm aspheric optic, and a variable overall length 
depending on its power (11.0 mm: 0 to 15.0 D, 10.7 mm: 
15.25 to 22.0 D, and 10.5 mm: 22.25 to 32.0 D). It has a 4 
point-fixation haptics and a continuous 360° posterior 
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square optic edge, with a shift aimed at promoting capsular 
bag adhesion (angulation 0º). It is made of a hydrophilic 
acrylic material with a refractive index of 1.459. The IOL 
has a continuous area with an EDOF central zone, 
a patented transition zone and monofocal optical periphery, 
generating a combination of primary and secondary sphe-
rical aberrations of opposite signs promoting an increase of 
the depth of field. The company labelled A-constant for this 
IOL is 118.0. The IOL power calculations were conducted 
in this study using the Barrett Universal II (BU-II) formula 
and considering a target refraction of emmetropia in the 
dominant eye and minimal myopic refractive error (around 
−0.50 D) in the non-dominant eye.
Data Analysis
The SPSS software package (SPSS Version 20.0; IBM 
Corporation, Armonk, NY, USA) was used to perform 
the analysis of data obtained in this study. Normality of 
data samples was evaluated by means of the Kolmogorov– 
Smirnov test. When parametric analysis was possible, the 
Student’s t-test for paired data was used for the analysis of 
differences between preoperative and postoperative visits, 
whereas the Wilcoxon ranked sum test was used for such 
purpose when the data samples were not normally distrib-
uted. A p-value below 0.05 was considered as a criterion 
of statistical significance.
Results
A total of 27 eyes from 16 patients ranging in age from 49 
to 84 years were included in the study. Monocular implan-
tation of the IOL was performed in 5 patients (31.3%). In 
the 11 patients having a bilateral implantation of the IOL, 
a symmetric target refraction was planned in 7 patients 
(43.8%), whereas a micromonovision approach was 
planned in 4 patients (25%) (4 eyes with a myopic target 
of −0.50 D or more). The sample was comprised of 10 
females (62.5%) and 6 males (37.5%). Mean axial length, 
anterior chamber depth and keratometry were 23.91 mm 
(standard deviation, SD: 1.13; median: 23.74; range: 22.03 
to 26.25 mm), 2.94 mm (SD: 0.34; median: 3.00; range: 
2.14 to 3.37 mm), and 42.19 D (SD: 2.01; median: 42.25; 
range: 39.00 to 46.15 D), respectively. Mean IOL power 
implanted was 21.78 D (standard deviation, SD: 2.96; 
median: 21.00; range: 17.50 to 28.50 D).
Table 1 summarizes the preoperative and 3-month post-
operative monocular visual and refractive data. Changes in 
manifest refraction did not reach statistical significance 
(p≥0.249) mainly due to the large variability of the preopera-
tive data. However, a statistically significant improvement was 
observed in UDVA and CDVA (p=0.001). Likewise, 
a statistically significant improvement was found in UNVA 
(p<0.001). A total of 84.6% (22/26), 91.7% (22/24), and 
96.3% (26/27) of eyes achieved UDVA, UNVA and CDVA 
Table 1 Summary of the Preoperative and Postoperative Monocular Visual and Refractive Data of the Analyzed Sample
Mean (SD) Preoperative 3 Months Postop p-value
Median (Range)
LogMAR UDVA 0.69 (0.65) 0.11 (0.17) 0.001
0.45 (0.09 to 2.00) 0.06 (−0.07 to 0.70)
LogMAR CDVA 0.20 (0.24) 0.04 (0.11) 0.001
0.12 (0.00 to 0.82) 0.00 (−0.07 to 0.38)
Sphere (D) 0.10 (3.46) −0.49 (0.51) 0.249
0.63 (−9.75 to 5.50) −0.50 (−1.50 to 0.50)
Cylinder (D) −0.70 (0.70) −0.53 (0.45) 0.732
−0.50 (−2.50 to 0.00) −0.50 (−1.50 to 0.00)
SE (D) −0.25 (3.64) −0.76 (0.53) 0.372
0.50 (−11.00 to 4.88) −0.88 (−1.62 to 0.12)
LogMAR UNVA 0.99 (0.66) 0.14 (0.22) <0.001
1.00 (0.10 to 2.00) 0.10 (0.00 to 1.00)
LogMAR DCNVA — 0.37 (0.36) —
0.22 (0.00 to 1.00)
Abbreviations: UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity; UNVA, uncorrected near visual acuity; CNVA, corrected near visual 
acuity; DCNVA, distance-corrected near visual acuity; SE, spherical equivalent; D, diopters.
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of 0.20 logMAR or better at 3 months after surgery (Figure 1). 
A total of 78.6% of eyes achieved postoperative DCNVA of 
0.30 logMAR or better (Figure 1). A total of 85.2% (23/27), 
70.4% (19/27) and 74.1% (20/27) of eyes had a postoperative 
sphere, cylinder, and spherical equivalent within ±1.00 D, 
respectively (Figure 2). In addition, all eyes had a spherical 
equivalent within ±0.75 D of the target refraction.
Figure 3 shows the mean defocus curve measured at 3 
months after surgery in all cases enrolled in the study. As 
shown, the visual acuity was maintained on average over 
a value of 0.30 logMAR for the range of defocus levels 
between +1.00 and −1.50 D. The standard deviation of visual 
acuity measures increased as the more negative was the defo-
cus level (0 D, SD: 0.07; −1 D, SD: 0.12; −2 D, SD: 0.28; −3 
D, SD: 0.35) (Figure 3). Mean change in logMAR visual 
acuity from 0 to 1.5 D defocus levels was 0.27 (SD: 0.18; 
median: 0.26; range: −0.08 to 0.60).
No complications were detected and recorded during 
the follow-up.
Discussion
The clinical performance of a novel EDOF IOL based on 
the controlled induction of spherical aberration to expand 
the depth of focus has been evaluated in this case series. 
This is the first clinical experience with this new EDOF 
IOL reported to this date. The results obtained suggest that 
an enlargement of the depth of focus is induced with the 
implantation of this novel IOL, as the measurements of the 
defocus curve obtained show relatively functional levels of 
near and intermediate visual acuity while maintaining 
good levels of distance vision. Specifically, in the current 
series, mean 3-month postoperative monocular UDVA and 
UNVA values of 0.11 ± 0.17 and 0.14 ± 0.22 logMAR 
were obtained, respectively. This finding is consistent with 
the results of other studies evaluating the performance of 
other types of EDOF IOLs,7,8,13,17–19 although it should be 
noted that 4 micro-monovision cases were included in our 
sample. Giers et al18 evaluated an EDOF IOL also based 
on induction of controlled levels of spherical aberration 
(MiniWell Ready), obtaining median monocular UDVA 
and UNVA values of 0.13 and 0.14 logMAR, respectively, 
at 2–4 months after its implantation. Grabner et al7 
reported in patients implanted monocularly with the IC-8 
IOL (pinhole design) mean 1-month postoperative UDVA 
and UNVA values of 0.06 ± 0.08 and 0.11 ± 0.15 logMAR, 
respectively. Therefore, the EDOF IOL evaluated can 
Figure 1 Distribution of 3-month postoperative monocular visual acuity data in the analysed sample. 
Abbreviations: UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity; UNVA, uncorrected near visual acuity; DCNVA, distance-corrected 
near visual acuity.
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provide an intermediate and near visual performance com-
patible with that provided by other currently available 
EDOF IOL models.
The near visual performance with EDOF IOLs may be 
enhanced with a minimal residual myopic error in the non- 
dominant eye or in both eyes.10,14,22 This approach has 
been used in our series, with a mean postoperative sphe-
rical equivalent of −0.76 ± 0.53 D due to the inclusion of 4 
micro-monovision cases. This explains the difference 
between monocular postoperative UNVA (0.11 ± 0.15 
logMAR) and DCNVA (0.37 ± 0.36 logMAR), with values 
of this last visual parameter consistent with those reported 
for other refractive and diffractive EDOF 
IOLs.8,9,11,13,16,20 Mean DCNVA values of 0.32 ± 0.19 
and 0.39 ± 0.21 logMAR were reported by Reinhard 
et al9 at 6 months after implantation of the diffractive 
IOLs AT LARA 829MP and Tecnis Symfony. Savini et al20 
obtained a mean DCNVA of 0.35 ± 0.14 logMAR in 
Figure 2 Distribution of 3-month postoperative refractive data in the analysed sample. 
Abbreviation: SE, spherical equivalent.
Figure 3 Mean monocular defocus curve obtained at 3 months after surgery in the analysed sample.
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a group of 20 patients bilaterally implanted with the 
refractive EDOF IOL MiniWell. In the current series, the 
use of a micro-monovision or bilateral residual myopic 
approach with the EDOF IOL evaluated induces 
a significant enhancement of the near visual acuity perfor-
mance while preserving good levels of intermediate and 
distance vision.
Mean corrected distance visual acuities of 0.12 ± 0.12 and 
0.28 ± 0.19 logMAR were obtained for the defocus levels of 
−1 and −1.5 D of the defocus curve. This confirms that the 
EDOF IOL evaluated can provide functional levels of inter-
mediate vision, with outcomes comparable to those reported 
by previous authors evaluating other EDOF IOLs.7,13,16,17,20 
Savini et al16 demonstrated that the refractive EDOF IOL Mini 
Well increased the depth of focus through 2.0 D of defocus, 
with the best performance at 1.0 and 1.5 D of defocus. This 
same research group reported in another study evaluating the 
same refractive EDOF IOL mean postoperative distance- 
corrected visual acuity values of 0.08 ± 0.09 and 0.15 ± 0.11 
logMAR for the defocus of −1.0 and −1.5 D, respectively.20 
With the pinhole-based EDOF IOL IC-8, Grabner et al7 found 
that 100% of eyes maintained a 12-month postoperative visual 
acuity of 20/40 or better over a range of defocus from +0.50 to 
−1.50 D. In the current series, the corrected distance visual 
acuity was maintained on average over a value of 0.30 
logMAR for the range of defocus levels between +1.00 and 
−1.50 D. Likewise, a total of 78.6% of eyes achieved post-
operative DCNVA of 0.30 logMAR or better.
The present study has several limitations that should 
be acknowledged. First, the sample size is limited but it 
should be considered that this study was planned as 
a pilot research to evaluate the clinical performance of 
the new EDOF IOL evaluated. At this moment, a larger 
sample is being recruited to confirm in the future if these 
preliminary outcomes are corroborated in the short- and 
long-term follow-up. Second, only visual acuity and 
refractive data have been reported and therefore conclu-
sions about the impact of the implant of this IOL on 
optical quality cannot be extracted. Future studies should 
be conducted including the analysis of changes in con-
trast sensitivity, visual symptoms using a validated ques-
tionnaire and in ocular high order aberrations. Third, the 
current study is not comparative and the superiority of 
the performance of this EDOF IOL over a conventional 
monofocal IOL cannot be confirmed. This is an issue that 
should be investigated further in future comparative stu-
dies. Finally, the lack of a standardized approach in the 
refractive target planning created an inhomogeneous 
group of patients making some of the data (especially 
UDVA and UNVA) difficult to interpret.
In conclusion, the implantation of the Synthesis plus 
EDOF IOL after cataract surgery seems to provide func-
tional levels of distance, intermediate and near visual 
acuity. The near visual acuity with this new IOL can be 
enhanced using a micro-monovision or bilateral residual 
myopic approach, targeting some minimal level of residual 
myopia. More research is still needed to evaluate the 
impact of this EDOF IOL on visual quality and its advan-
tage over other presbyopia-correcting options that are cur-
rently available. Furthermore, the results of this pilot study 
should be confirmed in future comparative clinical trials.
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